Role of proteomics in translational research in cervical cancer (Q36381224)

13 August 2017

1 reference

title

Role of proteomics in translational research in cervical cancer (English)

1 reference

13 August 2017

main subject

cervix uterine cancer

1 reference

Eun-Kyoung Yim

1

1 reference

13 August 2017

Jong-Sup Park

series ordinal

2

1 reference

13 August 2017

publication date

1 February 2006

1 reference

Expert Review of Proteomics

13 August 2017

published in

1 reference

13 August 2017

volume

3

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

21-36

1 reference

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Physical status and expression of HPV genes in cervical cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Interactions of the human papillomavirus E7 protein with cell cycle regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

The retinoblastoma gene family in differentiation and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Mass spectrometry and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

A tandem quadrupole/time-of-flight mass spectrometer with a matrix-assisted laser desorption/ionization source: design and performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Protein microarrays: meeting analytical challenges for clinical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Signal pathway profiling of prostate cancer using reverse phase protein arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Genomic and proteomic expression patterns in HPV-16 E6 gene transfected stable human carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Bax and Bak independently promote cytochrome C release from mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

TRAF6 is a signal transducer for interleukin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Protein profiling and identification of modulators regulated by the E7 oncogene in the C33A cell line by proteomics and genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Protein profiling and identification of modulators regulated by human papillomavirus 16 E7 oncogene in HaCaT keratinocytes by proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Regulation of HSP60 mRNA expression in a human ovarian carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Cytosolic chaperonin is up-regulated during cell growth. Preferential expression and binding to tubulin at G(1)/S transition through early S phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Interaction of human Ku70 with TRF2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Livin, a novel inhibitor of apoptosis protein family member

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Protein profiling of cervical cancer by protein-biochips: proteomic scoring to discriminate cervical cancer from normal cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Docetaxel versus paclitaxel for antiangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Metabolism and mechanism of action of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Proteomic analysis of antiproliferative effects by treatment of 5-fluorouracil in cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Cisplatin restores p53 function and enhances the radiosensitivity in HPV16 E6 containing SiHa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Repair of cisplatin--DNA adducts by the mammalian excision nuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Requirement for ERK activation in cisplatin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

Plasma Prealbumin in Women with Epithelial Ovarian Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14789450.3.1.21

21 January 2018

Identifiers

DOI

10.1586/14789450.3.1.21

1 reference

13 August 2017

1 reference